A Combination of Fluticasone and Salmeterol For Asthma
Fluticasone propionate, an inhaled corticosteroid, and salmeterol xinafoate, a long-acting beta2-adrenergic agonist, are now available together in a dry-powder inhaler for maintenance treatment of patients with asthma. The new combination is not recommended for treatment of acute bronchospasm or for treatment of children less than 12 years old....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: A Combination of Fluticasone and Salmeterol For Asthma
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1102
Article Code: 1102a
Date: April 16, 2001
Volume: 43
Pages: 31-33
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1102
Article Code: 1102a
Date: April 16, 2001
Volume: 43
Pages: 31-33
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)